Hepatocyte Nuclear Factor 4 Inhibits the Activity of Site A from the Rat Apolipoprotein AI Gene

Abstract

The pivotal role of apolipoprotein AI (Apo AI) in mediating reverse cholesterol transport has lead us to the study of transcription factors that influence the expression of this gene. Previous studies show that rat HNF-4 enhances the activity of a cis-acting site C in the rat Apo AI promoter. Since sites C and A share 80% homology, we have examined whether HNF-4 binds to and modulates the transcriptional activity of the A-motif. Results show that HNF-4 binds to site A. The transcriptional activity of site A in a human hepatoma cell line, HuH-7, increases 2-2.5-fold in the presence of antisense HNF-4, but the sense construct has no effect on the activity of the reporter template. The lack of an effect of HNF-4 on site A activity may be due to high endogenous levels of the factor in HuH-7 cells. However, in BHK cells HNF-4 clearly inhibits the transcriptional activity of site A. Together these findings suggest that in contrast to the enhancing effects of HNF-4 on site C, the same factor inhibits site A activity. Since hepatocytes normally contain the T3 receptor and this nuclear factor increases site A action, cotransfection of T3 receptor along with antisense HNF-4 further augments the activity of p5'A.CAT. In summary, rat HNF-4 binds to site A from rat Apo AI DNA, and this factor suppresses site A activity. HNF-4 interferes with the enhancer role of the T3 receptor and thus contributes negatively to the net expression of the Apo AI gene.

The Nuclear Receptors Peroxisome Proliferator-activated Receptor α and Rev-erbα Mediate the Species-specific Regulation of Apolipoprotein A-I Expression by Fibrates

“…Moreover, whereas HNF-4 is an important regulator of hepatic apoC-III gene transcription, this transcription factor appears of lesser importance for human apoA-I transcriptional regulation in HepG2 cells (71,72). In addition, the role of HNF-4 in controlling rat apoA-I gene transcription is unclear, since HNF-4 may inhibit and activate its transcription via the A and C sites, respectively (73,74). Finally, down-regulation of HNF-4 expression and competition for its binding would be expected to affect a wide array of genes in liver whose expression is controlled by HNF-4, such as human apoA-II and apoB (75).…”

Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance

“…In vitro translation for the linearized expression vectors containing menin cDNA was performed with [ 35 S]methionine by using the TNT kit (Promega) as described previously [37]. For the GST pulldown assay, a 50% suspension of GST-protein beads (50 ml), which contained up to 1.0 mg of protein, was resuspended in the same volume of binding buffer (20 mM Tris-HCl [pH 7.5], 0.12 M NaCl, 10% [vol/vol] glycerol, 0.055% 2-mercaptoethanol, 1 mM EDTA, 0.1 mM EGTA, 0.5 mM phenylmethylsulfonyl fluoride, and 0.5% Nonidet P-40).…”

Expression of HDL Receptor, CLA-1 in Human Smooth-Muscle Cells and Effect of Interferon-γ on its Regulation

“…Western blot analysis ISS10 cells were washed and scraped in PBS and lysed in the lysis buffer as described previously [23]. The proteins were resuspended under reducing conditions, and 10 g were fractionated by size on 7.5 % SDS-polyacrylamide gels and transferred to polyvinylidene difluoride (PVDF) membranes for immunoblotting.…”